SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-004608
Filing Date
2021-11-15
Accepted
2021-11-15 16:21:36
Documents
15
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srzn-20211110.htm   iXBRL 8-K 58722
2 EX-99.1 srzn-ex99_1.htm EX-99.1 242096
3 GRAPHIC img94851506_0.jpg GRAPHIC 10633
  Complete submission text file 0000950170-21-004608.txt   483769

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srzn-20211110_pre.xml EX-101.PRE 13012
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srzn-20211110.xsd EX-101.SCH 3127
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srzn-20211110_lab.xml EX-101.LAB 17602
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srzn-20211110_def.xml EX-101.DEF 13718
8 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20211110_htm.xml XML 6591
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39635 | Film No.: 211411032
SIC: 2836 Biological Products, (No Diagnostic Substances)